ScholarIQanswers from OpenAlex

The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial

PaperCitations, authors & open-access status

The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial is a paper indexed in ScholarIQ from OpenAlex.

How many citations does The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial have?

ScholarIQcitation count

The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial has 117 citations in the OpenAlex counts ScholarIQ stores.

When was The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial published?

ScholarIQyear

The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial has 2021 year in the ScholarIQ index.

What is the open-access status of The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial?

ScholarIQoa status

The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial has bronze oa status in the ScholarIQ index.

What is the DOI of The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial?

ScholarIQdoi

The DOI for The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial is on the source record.

What is the PMID of The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial?

ScholarIQpmid

The PMID for The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial is on the source record.

What is the OpenAlex record for The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial?

ScholarIQopenalex

The OpenAlex for The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial